A Discussion on Adult Mesenchymal Stem Cells for Drug delivery: Pros and Cons

References

• Gharpure KM Wu SY Li C Lopez-Berestein G Sood AK . Nanotechnology: future of oncotherapy. Clin. Cancer Res.21 (14), 3121–3130 (2015).
   PubMed Web of Science ®Google Scholar
• Munoz JL Bliss SA Greco SJ Ramkissoon SH Ligon KL Rameshwar P . Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucleic Acids2, e126 (2013).
   PubMedGoogle Scholar
• Josiah DT Zhu D Dreher F Olson J Mcfadden G Caldas H . Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma. Mol. Ther.18 (2), 377–385 (2010).
   PubMed Web of Science ®Google Scholar
• Bagci-Onder T Du W Figueiredo JL Martinez-Quintanilla J Shah K . Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells. Brain138 (Pt 6), 1710–1721 (2015).
   PubMedGoogle Scholar
• Sharma RR Pollock K Hubel A Mckenna D . Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion54 (5), 1418–1437 (2014).
   PubMed Web of Science ®Google Scholar
• Campagnoli C Roberts IA Kumar S Bennett PR Bellantuono I Fisk NM . Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood98 (8), 2396–2402 (2001).
   PubMed Web of Science ®Google Scholar
• Anker PS Noort WA Kruisselbrink AB et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol.31 (10), 881–889 (2003).
   PubMed Web of Science ®Google Scholar
• Ishikane S Ohnishi S Yamahara K et al. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells26 (10), 2625–2633 (2008).
   PubMed Web of Science ®Google Scholar
• Portmann-Lanz CB Schoeberlein A Huber A et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am. J. Obstet. Gynecol.194 (3), 664–673 (2006).
   PubMed Web of Science ®Google Scholar
• Lee OK Kuo TK Chen WM Lee KD Hsieh SL Chen TH . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood103 (5), 1669–1675 (2004).
   PubMed Web of Science ®Google Scholar
• Musina RA Belyavski AV Tarusova OV Solovyova EV Sukhikh GT . Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull. Exp. Biol. Med.145 (4), 539–543 (2008).
   PubMed Web of Science ®Google Scholar
• He Q Wan C Li G . Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells25 (1), 69–77 (2007).
   PubMed Web of Science ®Google Scholar
• Staszkiewicz J Gimble JM Manuel JA Gawronska-Kozak B . IFATS collection: stem cell antigen-1-positive ear mesenchymal stem cells display enhanced adipogenic potential. Stem Cells26 (10), 2666–2673 (2008).
   PubMed Web of Science ®Google Scholar
• Jakob M Hemeda H Janeschik S et al. Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev.19 (5), 635–644 (2010).
   PubMed Web of Science ®Google Scholar
• Tirino V Paino F D'aquino R Desiderio V De Rosa A Papaccio G . Methods for the identification, characterization and banking of human DPSCs: current strategies and perspectives. Stem Cell Rev.7 (3), 608–615 (2011).
   Web of Science ®Google Scholar
• Tay CY Sathiyanathan P Chu SW Stanton LW Wong TT . Identification and characterization of mesenchymal stem cells derived from the trabecular meshwork of the human eye. Stem Cells Dev.21 (9), 1381–1390 (2012).
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ Chailakhjan RK Lalykina KS . The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet.3 (4), 393–403 (1970).
   PubMedGoogle Scholar
• Kuznetsov SA Mankani MH Gronthos S Satomura K Bianco P Robey PG . Circulating skeletal stem cells. J. Cell Biol.153 (5), 1133–1140 (2001).
   PubMed Web of Science ®Google Scholar
• Trzaska KA Kuzhikandathil EV Rameshwar P . Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells25 (11), 2797–2808 (2007).
   PubMed Web of Science ®Google Scholar
• Chan JL Tang KC Patel AP et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood107 (12), 4817–4824 (2006).
   PubMed Web of Science ®Google Scholar
• Da Silva Meirelles L Maistro Malta T De Deus Wagatsuma VM et al. Cultured human adipose tissue pericytes and mesenchymal stromal cells display a very similar gene expression profile. Stem Cells Dev. doi:10.1089/scd.0153 (2015) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Pierantozzi E Badin M Vezzani B et al. Human pericytes isolated from adipose tissue have better differentiation abilities than their mesenchymal stem cell counterparts. Cell Tissue Res.361 (3), 769–778 (2015).
   PubMed Web of Science ®Google Scholar
• Marriott S Baskir RS Gaskill C et al. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Am. J. Physiol. Cell Physiol.307 (8), C684–698 (2014).
   PubMed Web of Science ®Google Scholar
• Potian JA Aviv H Ponzio NM Harrison JS Rameshwar P . Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol.171 (7), 3426–3434 (2003).
   PubMed Web of Science ®Google Scholar
• Sherman LS Munoz J Patel SA Dave MA Paige I Rameshwar P . Moving from the laboratory bench to patients’ bedside: considerations for effective therapy with stem cells. Clin. Transl Sci.4 (5), 380–386 (2011).
   PubMed Web of Science ®Google Scholar
• Marigo I Dazzi F . The immunomodulatory properties of mesenchymal stem cells. Semin. Immunopathol.33 (6), 593–602 (2011).
   PubMed Web of Science ®Google Scholar
• Castillo M Liu K Bonilla L Rameshwar P . The immune properties of mesenchymal stem cells. Int. J. Biomed. Sci.3 (2), 76–80 (2007).
   PubMedGoogle Scholar
• Wynn RF Hart CA Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood104 (9), 2643–2645 (2004).
   PubMed Web of Science ®Google Scholar
• Mele V Muraro MG Calabrese D et al. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-beta. Int. J. Cancer134 (11), 2583–2594 (2014).
   PubMed Web of Science ®Google Scholar
• Pevsner-Fischer M Morad V Cohen-Sfady M et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood109 (4), 1422–1432 (2007).
   PubMed Web of Science ®Google Scholar
• Brandau S Jakob M Bruderek K et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE9 (9), e106903 (2014).
   PubMed Web of Science ®Google Scholar
• Németh K Leelahavanichkul A Yuen P et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med.15 (1), 42–49 (2009).
   PubMed Web of Science ®Google Scholar
• Conde-Green A Baptista LS De Amorin NF et al. Effects of centrifugation on cell composition and viability of aspirated adipose tissue processed for transplantation. Aesthet. Surg. J.30 (2), 249–255 (2010).
   PubMed Web of Science ®Google Scholar
• Vellasamy S Sandrasaigaran P Vidyadaran S George E Ramasamy R . Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J. Stem Cells4 (6), 53–61 (2012).
   PubMedGoogle Scholar
• Wang HS Hung SC Peng ST et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells22 (7), 1330–1337 (2004).
   PubMed Web of Science ®Google Scholar
• Pallua N Pulsfort AK Suschek C Wolter TP . Content of the growth factors bFGF, IGF-1, VEGF, and PDGF-BB in freshly harvested lipoaspirate after centrifugation and incubation. Plast. Reconstr. Surg.123 (3), 826–833 (2009).
   PubMed Web of Science ®Google Scholar
• Dominici M Le Blanc K Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy8 (4), 315–317 (2006).
   PubMed Web of Science ®Google Scholar
• Bernardo ME Zaffaroni N Novara F et al. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res.67 (19), 9142–9149 (2007).
   PubMed Web of Science ®Google Scholar
• Prockop DJ Brenner M Fibbe WE et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy12 (5), 576–578 (2010).
   PubMed Web of Science ®Google Scholar
• Di Nicola M Carlo-Stella C Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood99 (10), 3838–3843 (2002).
   PubMed Web of Science ®Google Scholar
• Aggarwal S Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood105 (4), 1815–1822 (2005).
   PubMed Web of Science ®Google Scholar
• Le Blanc K Samuelsson H Gustafsson B et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia21 (8), 1733–1738 (2007).
   PubMed Web of Science ®Google Scholar
• Ghannam S Bouffi C Djouad F Jorgensen C Noel D . Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res. Ther.1 (1), 2 (2010).
   PubMed Web of Science ®Google Scholar
• Augello A Tasso R Negrini SM et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol.35 (5), 1482–1490 (2005).
   PubMed Web of Science ®Google Scholar
• Stagg J Pommey S Eliopoulos N Galipeau J . Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood107 (6), 2570–2577 (2006).
   PubMed Web of Science ®Google Scholar
• Li G Yuan L Ren X et al. The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clin. Exp. Immunol.173 (1), 28–37 (2013).
   PubMed Web of Science ®Google Scholar
• Baraniak PR Mcdevitt TC . Stem cell paracrine actions and tissue regeneration. Regen. Med.5 (1), 121–143 (2010).
   PubMed Web of Science ®Google Scholar
• Francois M Romieu-Mourez R Stock-Martineau S Boivin MN Bramson JL Galipeau J . Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood114 (13), 2632–2638 (2009).
   PubMed Web of Science ®Google Scholar
• Desai MB Gavrilova T Liu J et al. Pollen-induced antigen presentation by mesenchymal stem cells and T cells from allergic rhinitis. Clin. Transl. Immunology2 (10), e7 (2013).
   PubMedGoogle Scholar
• Ren G Zhang L Zhao X et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell2 (2), 141–150 (2008).
   PubMed Web of Science ®Google Scholar
• Valencic E Loganes C Cesana S et al. Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media. Stem Cell Res. Ther.5 (1), 3 (2014).
   PubMedGoogle Scholar
• Honczarenko M Le Y Swierkowski M Ghiran I Glodek AM Silberstein LE . Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells24 (4), 1030–1041 (2006).
   PubMed Web of Science ®Google Scholar
• Osaka M Honmou O Murakami T et al. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res.1343, 226–235 (2010).
   PubMed Web of Science ®Google Scholar
• Cornelissen AS Maijenburg MW Voermans MA . Organ-specific migration of mesenchymal stromal cells: who, when, where and why?Immunol. Lett. doi:10.1016/j.imlet.06.019 (2015) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Lei J Hui D Huang W et al. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells. Int. J. Biochem. Cell Biol.45 (11), 2431–2443 (2013).
   PubMed Web of Science ®Google Scholar
• Iso Y Spees JL Serrano C et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun.354 (3), 700–706 (2007).
   PubMed Web of Science ®Google Scholar
• Arslan F Lai RC Smeets MB et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res.10 (3), 301–312 (2013).
   PubMed Web of Science ®Google Scholar
• Patel N Klassert TE Greco SJ et al. Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev.21 (2), 308–320 (2012).
   PubMed Web of Science ®Google Scholar
• Chen J Li C Chen L . The role of microvesicles derived from mesenchymal stem cells in lung diseases. Biomed. Res. Int.2015, 985814 (2015).
   PubMed Web of Science ®Google Scholar
• Ji R Zhang B Zhang X et al. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle14 (15), 2473–2483 (2015).
   PubMed Web of Science ®Google Scholar
• Ratajczak J Miekus K Kucia M et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia20 (5), 847–856 (2006).
   PubMed Web of Science ®Google Scholar
• Kosaka N Iguchi H Yoshioka Y Takeshita F Matsuki Y Ochiya T . Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem.285 (23), 17442–17452 (2010).
   PubMed Web of Science ®Google Scholar
• Valadi H Ekstrom K Bossios A Sjostrand M Lee JJ Lotvall JO . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol.9 (6), 654–659 (2007).
   PubMed Web of Science ®Google Scholar
• Lim PK Bliss SA Patel SA et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res.71 (5), 1550–1560 (2011).
   PubMed Web of Science ®Google Scholar
• Khubutiya MS Vagabov AV Temnov AA Sklifas AN . Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy16 (5), 579–585 (2014).
   PubMed Web of Science ®Google Scholar
• Wu Y Chen L Scott PG Tredget EE . Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells25 (10), 2648–2659 (2007).
   PubMed Web of Science ®Google Scholar
• Qiao L Xu ZL Zhao TJ Ye LH Zhang XD . Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett.269 (1), 67–77 (2008).
   PubMed Web of Science ®Google Scholar
• Ramasamy R Lam EW Soeiro I Tisato V Bonnet D Dazzi F . Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia21 (2), 304–310 (2007).
   PubMed Web of Science ®Google Scholar
• Sun B Roh KH Park JR et al. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy11 (3), 289–298 (2009).
   PubMed Web of Science ®Google Scholar
• Miletic H Fischer Y Litwak S et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther.15 (7), 1373–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Niess H Von Einem JC Thomas MN et al. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a Phase I/II clinical trial. BMC Cancer15, 237 (2015).
   PubMed Web of Science ®Google Scholar
• Forbes GM Sturm MJ Leong RW et al. A Phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol.12 (1), 64–71 (2014).
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D Garcia-Arranz M Herreros D Pascual I Peiro C Rodriguez-Montes JA . A Phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum48 (7), 1416–1423 (2005).
   PubMed Web of Science ®Google Scholar
• Trivedi HL Vanikar AV Thakker U et al. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc.40 (4), 1135–1139 (2008).
   PubMed Web of Science ®Google Scholar
• Aleynik A Gernavage KM Mourad Y et al. Stem cell delivery of therapies for brain disorders. Clin. Transl. Med.3, 24 (2014).
   PubMedGoogle Scholar
• Choi SA Lee YE Kwak PA et al. Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas. Cancer Gene Ther.22 (6), 302–311 (2015).
   PubMed Web of Science ®Google Scholar
• Li Q Wijesekera O Salas SJ et al. Mesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survival. Clin. Cancer Res.20 (9), 2375–2387 (2014).
   PubMed Web of Science ®Google Scholar
• Rameshwar P . Mesenchymal stem cells can be a conduit for the delivery of therapeutic microRNA. J. Stem Cell Res. Ther.3 (1), e112 (2013).
   Google Scholar
• Olson SD Kambal A Pollock K et al. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Mol. Cell. Neurosci.49 (3), 271–281 (2012).
   PubMed Web of Science ®Google Scholar
• Kamaci N Emnacar T Karakas N Arikan G Tsutsui K Isik S . Selective silencing of DNA topoisomerase IIbeta in human mesenchymal stem cells by siRNAs (small interfering RNAs). Cell Biol. Int. Rep. (2010)18 (1), e00010 (2011).
   PubMedGoogle Scholar
• Smith CL Chaichana KL Lee YM et al. Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer. Stem Cells Transl. Med.4 (3), 239–251 (2015).
   PubMed Web of Science ®Google Scholar
• Zhu M Feng Y Dangelmajer S et al. Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1. Stem Cells Dev.24 (2), 160–171 (2015).
   PubMed Web of Science ®Google Scholar
• Eggenhofer E Benseler V Kroemer A et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol.3, 297 (2012).
   PubMed Web of Science ®Google Scholar
• Mcdonald CA Oehme D Pham Y et al. Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells. Cytotherapy17 (9), 1178–1187 (2015).
   PubMed Web of Science ®Google Scholar
• Diez-Tejedor E Gutierrez-Fernandez M Martinez-Sanchez P et al. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a Phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. J. Stroke Cerebrovasc. Dis.23 (10), 2694–2700 (2014).
   PubMed Web of Science ®Google Scholar
• Le Blanc K Frassoni F Ball L et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a Phase II study. Lancet371 (9624), 1579–1586 (2008).
   PubMed Web of Science ®Google Scholar
• Machula H Ensley B Kellar R . Electrospun tropoelastin for delivery of therapeutic adipose-derived stem cells to full-thickness dermal wounds. Adv. Wound Care3 (5), 367–375 (2014).
   Google Scholar
• Jayasinghe SN . Bio-electrosprays: from bio-analytics to a generic tool for the health sciences. Analyst136 (5), 878–890 (2011).
   PubMed Web of Science ®Google Scholar
• Jayasinghe SN . Cell electrospinning: a novel tool for functionalising fibres, scaffolds and membranes with living cells and other advanced materials for regenerative biology and medicine. Analyst138 (8), 2215–2223 (2013).
   PubMed Web of Science ®Google Scholar
• Guiro K Patel SA Greco SJ Rameshwar P Arinzeh TL . Investigating breast cancer cell behavior using tissue engineering scaffolds. PLoS ONE10 (3), e0118724 (2015).
   PubMedGoogle Scholar
• Jayasinghe SN Qureshi AN Eagles PA . Electrohydrodynamic jet processing: an advanced electric-field-driven jetting phenomenon for processing living cells. Small2 (2), 216–219 (2006).
   PubMed Web of Science ®Google Scholar
• Townsend-Nicholson A Jayasinghe SN . Cell electrospinning: a unique biotechnique for encapsulating living organisms for generating active biological microthreads/scaffolds. Biomacromolecules7 (12), 3364–3369 (2006).
   PubMed Web of Science ®Google Scholar
• Hwang CW Johnston PV Gerstenblith G et al. Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. Biomaterials52, 318–326 (2015).
   PubMed Web of Science ®Google Scholar
• Jahani H Kaviani S Hassanpour-Ezatti M Soleimani M Kaviani Z Zonoubi Z . The effect of aligned and random electrospun fibrous scaffolds on rat mesenchymal stem cell proliferation. Cell J.14 (1), 31–38 (2012).
   PubMed Web of Science ®Google Scholar
• Le Blanc K Tammik C Rosendahl K Zetterberg E Ringden O . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol.31 (10), 890–896 (2003).
   PubMed Web of Science ®Google Scholar
• Ankrum JA Ong JF Karp JM . Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol.32 (3), 252–260 (2014).
   PubMed Web of Science ®Google Scholar
• Talmadge JE . Clonal selection of metastasis within the life history of a tumor. Cancer Res.67 (24), 11471–11475 (2007).
   PubMed Web of Science ®Google Scholar
• Patel SA Meyer JR Greco SJ Corcoran KE Bryan M Rameshwar P . Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J. Immunol.184 (10), 5885–5894 (2010).
   PubMed Web of Science ®Google Scholar
• Ono M Kosaka N Tominaga N et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci. Signal7 (332), ra63 (2014).
   PubMed Web of Science ®Google Scholar
• Mishra PJ Mishra PJ Humeniuk R et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res.68 (11), 4331–4339 (2008).
   PubMed Web of Science ®Google Scholar
• Spaeth EL Dembinski JL Sasser AK et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE4 (4), e4992 (2009).
   PubMed Web of Science ®Google Scholar
• Corcoran KE Trzaska KA Fernandes H et al. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS ONE3 (6), e2563 (2008).
   PubMed Web of Science ®Google Scholar
• Rameshwar P . Breast cancer cell dormancy in bone marrow: potential therapeutic targets within the marrow microenvironment. Expert Rev. Anticancer Ther.10 (2), 129–132 (2010).
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez R Francois M Boivin MN Stagg J Galipeau J . Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J. Immunol.179 (3), 1549–1558 (2007).
   PubMed Web of Science ®Google Scholar
• Lublin FD Bowen JD Huddlestone J et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult. Scler. Relat. Disord.3 (6), 696–704 (2014).
   PubMed Web of Science ®Google Scholar
• Chambers DC Enever D Ilic N et al. A Phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology19 (7), 1013–1018 (2014).
   PubMed Web of Science ®Google Scholar
• Vargas A Zhou S Ethier-Chiasson M et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J28 (8), 3703–3719 (2014).
   PubMed Web of Science ®Google Scholar
• Cheynet V Ruggieri A Oriol G et al. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J. Virol.79 (9), 5585–5593 (2005).
   PubMed Web of Science ®Google Scholar